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Abstract
Background Antimicrobial resistance may compromise
the efficacy of antibiotic prophylaxis before surgery. The
aim of this study was to measure susceptibility and clonal
distribution of coagulase-negative staphylococci (CoNS)
colonizing the skin around the surgery access site before
and after the procedure.
Methods From March to September 2004, a series of 140
patients undergoing elective major abdominal surgery were
screened for CoNS colonization at admission and 5 days
after surgery. All isolates were tested for antibiotic suscep-
tibility and genotyped by pulsed-field gel electrophoresis
(PFGE).
Results Colonization rates with CoNS at admission and
after surgery were 85% and 55%, respectively. The methi-
cillin-resistant CoNS rate increased from 20% at admission
to 47% after surgery (P = 0.001). The PFGE pattern after
surgery revealed more patients colonized with identical
clones: 8/140 patients (8/119 strains) and 26/140 patients
(26/77 strains), respectively (P \ 0.001).
Conclusions Our results suggest rapid recolonization of
disinfected skin by resistant nosocomial CoNS. Larger
studies, preferably among orthopedic or cardiovascular
patients, are required to clarify whether standard antibiotic
prophylaxis with first- or second-generation cephalosporins
for CoNS infections may be compromised if the patient
requires an additional intervention 5 days or more after the
initial surgery.
Introduction
Surgical site infection (SSI) is an important factor that
interferes with a successful surgical outcome and is
potentially associated with repercussions on the patient’s
future quality of life and extra costs generated by extended
hospitalization. The incidence of SSI depends on the sur-
gery class and its risk index [1]. Currently, coagulase-
negative staphylococci (CoNS) are the second most fre-
quent isolates identified after Staphylococcus aureus in the
field of surgery [1–3].
Together with surgical asepsis, antimicrobial prophy-
laxis is the recommended strategy to prevent SSI for most
clean and clean-contaminated surgical procedures [3, 4]. A
first- or second-generation cephalosporin is still the antibi-
otic of choice, either used alone or, when necessary as in
colorectal surgery, combined with an active agent for
anaerobes [3–5]. Routine vancomycin use is not recom-
mended [6]. There appears to be no evidence at present for
the increasing role of CoNS in SSIs, in particular for pro-
cedures where they are most prevalent (e.g., cardiac,
orthopedic, and vascular surgery) [7–9].
Given the high reported rate of methicillin-resistant
CoNS (MR-CoNS)—up to 80% in the literature—this is
surprising. A possible reason is that most surgical
This study was presented in part at the 45th Interscience Conference
on Antimicrobial Agents and Chemotherapy, December 2005,
Washington, DC (abstract no. K-1378).
W. Zingg  A. Imhof  G. Senn  C. Ruef
Division of Infectious Diseases and Hospital Epidemiology,
Department of Medicine, University Hospital of Zurich,
Ra¨mistrasse 100, 8091 Zurich, Switzerland
W. Zingg (&)
Infection Control Programme, University of Geneva Hospitals,
4 Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland
e-mail: walter.zingg@hcuge.ch
N. Demartines
Clinic of Visceral Surgery, Department of Surgery, University
Hospital of Zurich, Ra¨mistrasse 100, 8091 Zurich, Switzerland
123
World J Surg (2009) 33:2058–2062
DOI 10.1007/s00268-009-0167-3
procedures are carried out in patients entering the hospital
from the community, either for an elective procedure or
as an emergency case, and that the CoNS rate in the com-
munity is much lower than in the hospital where most
information about CoNS susceptibility is obtained. The
Sentinel Surveillance of Antibiotic Resistance in Switzer-
land (SEARCH) study (http://www.search.ifik.unibe.ch)
has begun recently to report MR-CoNS rates. The rate of
oxacillin-resistant CoNS in the outpatient setting was 35%
for 2008. However, this proportion may be overestimated
as the database contains only results from microbiology
laboratories, and there is no information on whether
patients found with MR-CoNS were hospitalized recently.
Data are lacking on the colonization process of CoNS in
the health care environment, and it remains unknown
whether recolonization of disinfected skin occurs from the
patients’ intrinsic flora or the hospital environment.
In the present study, a cohort of elective surgery patients
were screened for CoNS colonization at the site of skin
incision at admission and 5 days after surgery. The aim was
to assess the process of skin recolonization with CoNS
around the surgery access site after intervention by mea-
suring both susceptibility and clonal distribution in an
unselected population of general surgery patients.
Methods
Setting and study population
This prospective cohort study was conducted from March to
September 2004 at the department of visceral and transplant
surgery of the University Hospital of Zurich, a 960-bed,
tertiary-care, teaching hospital in northern Switzerland, in
collaboration with the hospital epidemiology team. Con-
secutive adult patients ([16 years of age) admitted for
elective major abdominal surgery were screened for CoNS
skin colonization at admission and 5 days after surgery (or
at the time of hospital discharge in case of a shorter stay).
Patients scheduled for the following elective surgical pro-
cedures were included.
• Upper gastrointestinal surgery: gastric or esophagus
resection for cancer; major liver and pancreas resection
for malignancy
• Colorectal surgery: right and left colectomy; rectum
resection for cancer
• Various indications: mainly living donor nephrectomy
Surgical site disinfection was standardized according to
institutional rules and performed with povidone–iodine
solution; antibiotic prophylaxis was performed according
to internal guidelines with cefazolin within 1 h before skin
incision. The anesthetists’ protocols were checked to
ensure correct performance of surgical prophylaxis.
Only patients with a complete set of screening tests
preoperatively and postoperatively were included in the
final analysis. The study was approved as a quality
improvement project by the institution’s ethics committee,
and patients were informed of the study’s objective.
Screening and culture procedures
The screening test at admission was performed with a skin
swab according to our standardized surgical approach
(laparotomy or laparoscopy) based on a standardized
frame. Skin swabs after surgery were performed within the
same area. Patient demographic characteristics, operative
procedures, length of stay, previous hospitalization within
the last 12 months, and selection of preoperative antibiotic
prophylaxis were recorded for risk analysis.
Bacterial culture and CoNS identification were done
according to the protocols of the Clinical and Laboratory
Standards Institute. Colonies of different morphology on the
agar plate were subtyped. Susceptibility testing for oxacillin
was performed using a disk diffusion technique with disks of
1 lg oxacillin on Mueller–Hinton agar (Oxoid, Basingstoke,
UK). For cefalothin, cefuroxim, ciprofloxacin, and vanco-
mycin, minimal inhibitory concentrations (MIC) were per-
formed using Etest (AB Biodisk, Solna, Sweden). All CoNS
isolates were genotyped by pulsed-field gel electrophoresis
(PFGE) as previously described [10, 11]. Banding patterns
of the PFGE results were analyzed using GelCompar II
software (Applied Maths BVBA, Sint-Martens-Latem,
Belgium).
Statistical analysis
Continuous variables were summarized by means or
medians (interquartile range). Nonparametric statistical
tests were used as appropriate. Continuous variables were
compared with the Mann–Whitney U-test or Kruskal–
Wallis analysis of variance, whereas discontinuous vari-
ables were compared with the v2 test. Risk factor analysis
for colonization with CoNS exhibiting reduced suscepti-
bility at either admission or discharge was conducted using
univariate logistic regression. All tests were two-tailed, and
P \ 0.05 was considered statistically significant. All sta-
tistical analyses were conducted using Stata 10 (Stata,
College Station, TX, USA).
Results
In all, 140 patients were included in the study. Patient
demographics and characteristics are summarized in
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Table 1. Cefazolin was the most frequently used antimi-
crobial agent for antibiotic prophylaxis (92.9%, 130/140)
followed by amoxicillin-clavulanate (1.4%, 2/140). Two
patients were under treatment with piperacillin/tazobactam
and one patient with ciprofloxacin. Five patients had no
documentation of receiving any antibiotic prophylaxis
(3.6%). Sixteen patients undergoing colorectal surgery
received metronidazole in addition to cefazolin.
At admission, CoNS was found in 119 patients (85%) in
the area of the planned surgical access site. After surgery,
77 (55%) patients were positive for CoNS at the surgical
site. No bacterial growth was found in 10 patients (8%) at
admission, but it was observed in 56 (40%) after surgery
(Table 2). On the basis of a different morphology on the
agar plate, 168 CoNS strains were identified at admission
and 108 after surgery. A total of 65 patients were colonized
with CoNS both at admission and after surgery.
The prevalence of oxacillin resistance increased from
20% of isolated strains (34/168 strains among 32 patients)
at admission to 47% (51/108 strains among 43 patients)
after surgery (P = 0.001). Altogether, 31 patients, either
colonized with susceptible CoNS or not colonized, were
found with oxacillin-resistant CoNS (MR-CoNS) after
surgery. There was a significant reduction of susceptibility
to cefalothin before and after surgery (MIC90 was 0.75 lg/
ml before surgery and 3 lg/ml after surgery: P \ 0.001),
cefuroxime (MIC90 4 lg/ml and 256 lg/ml, respectively;
P \ 0.001), and ciprofloxacin (MIC90 1 lg/ml and 32 lg/
ml, respectively; P \ 0.001). This reduction was due not
only to the higher proportion of MR-CoNS, 51% of MR-
CoNS and 4% of oxacillin-susceptible CoNS showed
reduced susceptibility to ciprofloxacin (P \ 0.001). No
reduced susceptibility to vancomycin was observed.
Significantly more patients were found with identical
clones in the PFGE analysis after surgery than at admis-
sion: 8/140 patients (8/119 strains) and 26/140 patients
(26/77 strains), respectively (P \ 0.001). Only four clones
colonizing 2 patients each were detected at admission,
whereas seven clones colonizing 26 patients were identi-
fied after surgery. Of the latter, one particular clone was
found to colonize 10 patients. Other clones colonized three
(four clones) or two (two clones) patients, respectively. Six
of the seven identified clones after surgery, including the
predominant clone colonizing 10 patients, were methicil-
lin-resistant. Eight patients (6%) were found with identical
clones at admission and after surgery. The susceptibility of
these clones did not change during hospitalization. All
other patients were found with different clones at admis-
sion and after surgery.
Risk factor analysis for MR-CoNS colonization at
admission did not reveal significant results regarding age,
sex, or hospitalization during the previous 12 months.
Length and choice of prophylactic antibiotic administration
were not significant risk factors for MR-CoNS colonization
at discharge. Four surgical site infections (3%) were found
among our patients.
Discussion
This study shows that most of our patients scheduled for
major elective general surgery were colonized with CoNS
at the time of hospitalization. Despite a strict antibiotic
Table 1 Characteristics of patients with elective major abdominal
surgery screened for coagulase-negative staphylococcus coloniza-
tion—University Hospital of Zurich, March to September 2004
Characteristic Result
Age (years), median (IQR) 52 (42–63)
Male sex (%) 69 (49.3%)
Length of hospital stay (days), median (IQR) 9 (7–14)
Hospitalization during preceding 12 months (%) 59 (42%)
Surgical procedures (%)
Upper gastrointestinal surgery 50 (36%)
Colorectal surgery 27 (19%)
Various indications 63 (45%)
Preoperative antibiotic prophylaxis (%)
Cefazolin 130 (93%)
Amoxicillin/clavulanic acid 2 (1%)
Piperacillin/tazobactama 2 (1%)
Ciprofloxacina 1 (1%)
Metronidazole added 16 (11%)
No prophylaxis 5 (4%)
Nosocomial infections
Surgical site infectionsb 4 (3%)
Pneumonia 1 (1%)
IQR interquartile range
a Ongoing antibiotic treatment at the time of surgery
b The following pathogens were isolated: Enterococcus faecalis (1),
Enterobacter cloacae (1), no growth (2)
Table 2 Findings of skin swabs among patients screened for coag-
ulase-negative staphylococcus colonization at admission and after
surgery—University Hospital of Zurich, March to September 2004
Culture
results
No. of patients
before surgery
No. of patients with culture
results after surgery
CoNS No CoNSa No growth
CoNS 119 65 6 48
No CoNSa 11 7 1 3
No growth 10 5 0 5
Total 140 77 7 56
CoNS coagulase-negative staphylococci
a Bacteria other than coagulase-negative staphylococci
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prophylaxis policy with a single-shot, second-generation
cephalosporin, a significant postoperative increase in MR-
CoNS was observed together with a significant decrease in
cephalosporin susceptibility.
Preoperative antibiotic prophylaxis is clearly one of the
most effective measures for SSI prevention [12–14]. Based
on several well conducted studies, single-dose regimens
with first- or second-generation cephalosporins are rec-
ommended for most surgical procedures unless methicillin-
resistant Staphylococcus aureus is a concern [15]. The role
of MR-CoNS colonization before surgery and its impact on
the occurrence of SSIs is unclear, and there is a paucity of
data on the prevalence of MR-CoNS in the community.
During the 1980s, Larson et al. reported 2.9% MR-
CoNS skin colonization in the community [16]. More
recent studies reporting on CoNS susceptibility were con-
ducted in hospital settings, and CoNS susceptibility was
not even the main outcome parameter. CoNS were pre-
dominantly isolated from nosocomial infections, mainly
bloodstream or wound infections [7–9]; and not unex-
pectedly, MR-CoNS rates were high ([80% in some
studies). Thus, the MR-CoNS colonization rate in the
community cannot be deduced from such data, and that
from Larson et al. dates too far back. In 2008, the Swiss
SEARCH study reported a MR-CoNS rate of 35% among
1,009 clinical isolates in the community, indicating that
most skin-colonizing CoNS are still methicillin-suscepti-
ble. However, as mentioned, the SEARCH data report only
results obtained from microbiological laboratories without
taking into consideration any patient data; thus, the MR-
CoNS rate may be overestimated. The rate of MR-CoNS at
admission in our study population was much lower (20% of
all isolated CoNS). Given that 42% of our patients were
hospitalized at least once during the preceding 12 months
and therefore were potentially exposed to nosocomial MR-
CoNS, the true rate of MR-CoNS among patients with no
history of any contact with a health care institution is likely
to be even lower. Knowledge of epidemiologic trends for
community MR-CoNS is important because most patients
scheduled for elective surgery enter the hospital directly
from the community.
Five days after surgery, more than half (55%) of our
patients were recolonized with CoNS at the incision site.
One-third were found to be colonized with CoNS strains
with a PFGE pattern identical to that of isolates found in
other patients; the proportion of methicillin resistance
among these strains was significantly higher than in non-
identical strains after surgery (P \ 0.001). The high prev-
alence of identical strains after surgery plus the high MR-
CoNS rate strongly suggest that recolonization of the dis-
infected skin area after surgery originated from the hospital
environment. Such recolonization may put the patient at
risk when an additional surgical procedure is required and
antibiotic prophylaxis is not adapted in consequence.
None of the oxacillin-susceptible CoNS showed reduced
susceptibility to cefalothin or cefuroxim. Consistent with
the published literature, half of the MR-CoNS showed
reduced susceptibility to ciprofloxacin [17–20]. However,
the overall resistance of oxacillin-susceptible CoNS against
ciprofloxacin was low.
This study has some limitations. Abdominal surgery
may not be the ideal cohort for studying the impact of
reduced CoNS susceptibility because other microorganisms
are more likely to be involved. However, postoperative
recolonization of disinfected skin with nosocomial patho-
gens is a basic principle that is applicable to all surgical
procedures and may include even multiresistant gram-
negative organisms. SSI was not the primary endpoint of
our study. Larger studies, preferably among orthopedic or
cardiovascular patients, should address the question of
whether the use of standard antibiotic prophylaxis is
associated with more SSIs in patients who require an
additional intervention after the initial surgery.
Conclusions
Our study shows that (1) the prevalence of skin MR-CoNS
in the community is lower than in the hospital, (2) skin
recolonization of the disinfected surgery field with CoNS
occurs rapidly after surgery, and (3) such recolonization is
likely due to nosocomial strains rather than to the endog-
enous flora of the patient. However, larger studies, pref-
erably among orthopedic or cardiovascular patients, are
required to clarify whether standard antibiotic prophylaxis
with first- or second-generation cephalosporins for CoNS
infections may be compromised if the patient requires an
additional intervention at the same site 5 days or more after
the initial surgery.
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